The Federal Register

National Heart, Lung, and Blood Institute (NHLBI): Opportunity for Cooperative Research and Development Agreements

Fri, Dec 5 2003 11:00:00 GMT

The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) announces the opportunity for Cooperative Research and Development Agreements (CRADAs) to develop novel mechanical and biological treatments in interventional cardiovascular medicine using xray fluoroscopy and realtime magnetic resonance imaging. The NHLBI seeks potential Collaborators wishing to provide expertise in (1) novel biological treatments for cardiovascular disease, including agents to facilitate mobilization of bonemarrow derived stem and progenitor cells, (2) novel agents for therapeutic angiogenesis for myocardial or peripheral artery applications, (3) novel immunemodulating agents to treat to prevent manifestations of atherosclerosis, coronary artery occlusion, or myocardial ischemia/ infarction, (4) novel mechanisms of drug, gene, or cell delivery to the myocardium or skeletal muscle to treat manifestations of coronary or peripheral artery atherosclerosis, and (5) intravascular devices

Government-Owned Inventions; Availability for Licensing

Fri, Dec 5 2003 11:00:00 GMT

The inventions listed below are owned by an agency of the U.S. Government and are available for licensing in the U.S. in accordance with 35 U.S.C. 207 to achieve expeditious commercialization of results of federallyfunded research and development. Foreign patent applications are filed on selected inventions to extend market coverage for companies and may also be available for licensing.

National Institute of Child Health and Human Development; Notice of Meeting

Fri, Dec 5 2003 11:00:00 GMT

Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the National Advisory Board on Medical Rehabilitation Research.

The meeting will be open to the public with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.

Name of Committee: National Advisory Board on Medical Rehabilitation Research.

Date: December 89, 2003.

Time: December 8, 2003, 8:30 a.m. to 5 p.m.

Agenda: NICHD Director's Report presentation, Regional Research Networks, and an update on the Rehabilitation Medicine Scientist Training Program.

Place: Holiday InnSilver Spring, 8777 Georgia Avenue, Silver Spring, MD 20910.

Time: December 9, 2003, 8:30 a.m. to 12 p.m.

Agenda: Other business dealing with the NABMRR Board.

Place: Ho

National Institute of Diabetes and Digestive and Kidney Disease; Amended Notice of Meeting

Fri, Dec 5 2003 11:00:00 GMT

Notice is hereby given of a change in the meeting of the National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel, November 25, 2003, 9 a.m. to November 25, 2003, 11 a.m. National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD, 20892 which was published in the Federal Register on October 31, 2003, 68 FR 62902.

The meeting will be held on December 18, 2003 from 3 p.m. until 5 p.m. The meeting is closed to the public.

Dated: November 28, 2003.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 0330202 Filed 12403; 8:45 am]
BILLING CODE 414001M

National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting

Fri, Dec 5 2003 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal property.

Name of Committee: National Institute of Diabetes and Digestive Kidney Diseases Special Emphasis Panel, Chronic Kidney Disease.

Date: December 12, 2003.

Time: 3 p.m. to 4:30 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference Call).

National Institute of Mental Health; Notice of Closed Meeting

Fri, Dec 5 2003 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. appendix 2), notice is hereby given of the following meeting.

Name of Committee: National Institute of Mental Health Special Emphasis Panel.

Date: December 10, 2003.

Time: 10:30 a.m. to 1:30 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Call).

Contact Person: David I. Sommers, PhD, Sci

Center for Scientific Review; Amended Notice of Meeting

Fri, Dec 5 2003 11:00:00 GMT

Notice is hereby given of a change in the meeting of the Center for Scientific Review Special Emphasis Panel, December 18, 2003, 1 p.m. to December 18, 2003, 3 p.m., National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 which was published in the Federal Register on November 26, 2003, 68 FR 6647166472.

The meeting will be held on December 19, 2003, from 5 p.m. to 7 p.m. The location remains the same. The meeting is closed to the public.

Dated: November 28, 2003.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 0330201 Filed 12403; 8:45 am]
BILLING CODE 414001M